共 50 条
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
被引:146
|作者:
Gu, Wenyi
[1
,2
]
Wu, Chengtie
[3
]
Chen, Jiezhong
[1
]
Xiao, Yin
[1
]
机构:
[1] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia
[2] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia
[3] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China
来源:
INTERNATIONAL JOURNAL OF NANOMEDICINE
|
2013年
/
8卷
基金:
英国医学研究理事会;
关键词:
nanoparticles;
nanostructured scaffold;
cancer bone metastasis;
bone diseases;
target drug delivery;
bone regeneration;
MESOPOROUS BIOACTIVE GLASS;
BREAST-CANCER;
IN-VITRO;
PHOSPHATE SCAFFOLDS;
INTRAARTICULAR DELIVERY;
POLYMERIC NANOPARTICLES;
MECHANICAL-PROPERTIES;
SILICA NANOPARTICLES;
GOLD NANOPARTICLES;
CALCIUM SILICATE;
D O I:
10.2147/IJN.S44393
中图分类号:
TB3 [工程材料学];
学科分类号:
0805 ;
080502 ;
摘要:
Nanotechnology is a vigorous research area and one of its important applications is in biomedical sciences. Among biomedical applications, targeted drug delivery is one of the most extensively studied subjects. Nanostructured particles and scaffolds have been widely studied for increasing treatment efficacy and specificity of present treatment approaches. Similarly, this technique has been used for treating bone diseases including bone regeneration. In this review, we have summarized and highlighted the recent advancement of nanostructured particles and scaffolds for the treatment of cancer bone metastasis, osteosarcoma, bone infections and inflammatory diseases, osteoarthritis, as well as for bone regeneration. Nanoparticles used to deliver deoxyribonucleic acid and ribonucleic acid molecules to specific bone sites for gene therapies are also included. The investigation of the implications of nanoparticles in bone diseases have just begun, and has already shown some promising potential. Further studies have to be conducted, aimed specifically at assessing targeted delivery and bioactive scaffolds to further improve their efficacy before they can be used clinically.
引用
收藏
页码:2305 / 2317
页数:13
相关论文